For people with heart failure, getting a special pacemaker-like device called CRT-D can be a tough decision. It helps many, but for some, it might not work or could even make things worse. Doctors have been looking for a better way to predict who will truly benefit.
A new look at data from a major heart failure trial suggests a clue might be hiding in a standard electrocardiogram (ECG). Researchers focused on a specific electrical measurement called P0PV1. They found that among patients who only got a simpler defibrillator (ICD), those with the highest P0PV1 values had more than three times the risk of heart failure or death. But when those same high-risk patients got the CRT-D device instead, their risk of heart failure or death was 66% lower compared to the ICD.
The story flipped for patients with a very low P0PV1 value. For them, getting the CRT-D device was linked to a 64% *increased* risk of heart failure or death compared to the simpler ICD. This means the device's effect wasn't the same for everyone; it helped one group but potentially harmed another.
It's important to know this was a deep-dive analysis of existing trial data, not a new study designed to test this idea from the start. The researchers themselves say these findings need to be confirmed in future, prospective studies. For now, it's a promising signal that a simple, non-invasive test could one day help guide this critical treatment choice more precisely.